Clinical Trial Update: Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial assessing relacorilant with nab-paclitaxel and gemcitabine for metastatic pancreatic ductal adenocarcinoma. The trial is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (albumin-bound paclitaxel) (paclitaxel)
• Relacorilant (relacorilant)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Adenocarcinoma, Carcinoma, Pancreatic Ductal | Phase 2 | Status: RECRUITING